De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
NCT06692725
·
clinicaltrials.gov ↗
RECRUITING
Status
380
Enrollment
OTHER
Sponsor class
Conditions
Triple Negative Breast Cancer
Sponsor
Peking University People's Hospital